AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesInformation ScienceHealth Care
Cell CycleS Phase Cell Cycle CheckpointsG2 Phase Cell Cycle CheckpointsG1 Phase Cell Cycle CheckpointsM Phase Cell Cycle CheckpointsCell Cycle ProteinsG2 PhaseCell Cycle CheckpointsDNA DamageCheckpoint Kinase 2S PhaseG1 PhaseGenes, cdcAtaxia Telangiectasia Mutated ProteinsMitosisProtein-Serine-Threonine KinasesTumor Suppressor Protein p53Protein Kinasescdc25 PhosphatasesCyclin-Dependent Kinase Inhibitor p21DNA RepairCDC2 Protein KinaseDNA-Binding ProteinsCyclinsPhosphorylationCell DivisionApoptosisTumor Suppressor ProteinsCyclin B1Cell Line, TumorDNA ReplicationGamma RaysNuclear ProteinsAtaxia TelangiectasiaHydroxyureaRadiation, IonizingCell ProliferationCyclin BSpindle ApparatusRetinoblastoma ProteinRadiation ToleranceFlow CytometryG0 PhaseCyclin-Dependent Kinase 2Signal TransductionHeLa CellsCell LineMutationCyclin-Dependent KinasesCyclin-Dependent Kinase Inhibitor p27Genomic InstabilityCyclin D1Cyclin EUltraviolet RaysSaccharomyces cerevisiae ProteinsCell SurvivalNocodazoleSaccharomyces cerevisiaeSchizosaccharomycesTumor Cells, CulturedFibroblastsSchizosaccharomyces pombe ProteinsDNA Breaks, Double-StrandedRNA, Small InterferingCyclin-Dependent Kinase 4HistonesChromosomal InstabilityBlotting, WesternModels, BiologicalAntineoplastic Agents, PhytogenicMolecular Sequence DataCells, CulturedFungal ProteinsCell NucleusBRCA1 ProteinDNAMimosineAntineoplastic AgentsAllyl CompoundsInterphaseGenes, p53CDC2-CDC28 KinasesKinetochoresAphidicolinCyclin ADose-Response Relationship, RadiationIntracellular Signaling Peptides and ProteinsTranscription FactorsGene Expression Regulation, NeoplasticMethyl MethanesulfonateDNA Repair EnzymesProtein BindingAmino Acid SequenceTime FactorsCaffeineChromatinDose-Response Relationship, DrugNucleic Acid Synthesis InhibitorsBase SequenceCarrier Proteins

Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth. (1/266)

 (+info)

Knockdown of transient receptor potential canonical-1 reduces the proliferation and migration of endothelial progenitor cells. (2/266)

 (+info)

Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. (3/266)

 (+info)

A novel RING finger protein, Znf179, modulates cell cycle exit and neuronal differentiation of P19 embryonal carcinoma cells. (4/266)

 (+info)

Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells. (5/266)

 (+info)

Control of Cdc14 activity coordinates cell cycle and development in Caenorhabditis elegans. (6/266)

 (+info)

Mitotic catastrophe occurs in the absence of apoptosis in p53-null cells with a defective G1 checkpoint. (7/266)

 (+info)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. (8/266)

 (+info)